Valproate semisodium

Drug Profile

Valproate semisodium

Alternative Names: Depakote; Depakote ER; Divalproex sodium; Divalproex sodium DR 500mg tablets - Abbott Laboratories; Epival; Epival ER

Latest Information Update: 25 Mar 2017

Price : $50

At a glance

  • Originator Abbott Laboratories
  • Class Antiepileptic drugs; Antimanics; Antimigraines
  • Mechanism of Action GABA uptake inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • On Fast track

    Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Marketed Bipolar disorders; Epilepsy; Migraine

Most Recent Events

  • 17 Aug 2016 Biomarkers information updated
  • 02 Jan 2013 Abbott separates its pharmaceuticals business to a new company named AbbVie
  • 20 Dec 2005 Data presented at the 26th International Epilepsy Congress (IEC-2005) have been added to the therapeutic trials section
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top